Prevention of the Pro-Aggressive Effects of Ethanol-Intoxicated Mice by Schisandrin B

Excessive alcohol consumption can lead to serious health complications, with liver and neurological complications being the most important. In Western nations, alcoholic liver disease accounts for 50% of mortality from end-stage liver disease and is the second most common cause of liver transplants. In addition to direct damage, hepatic encephalopathy may also arise from alcohol consumption. However, effective treatment for liver disease, as well as neurological injury, is still lacking today; therefore, finding an efficacious alternative is urgently needed. In the current study, the preventive and therapeutic effects of Schisandrin B (Sch B) against ethanol-induced liver and brain injuries were investigated. By using two treatment models, our findings indicated that Sch B can effectively prevent and ameliorate alcoholic liver diseases, such as resolving liver injuries, lipid deposition, inflammasome activation, and fibrosis. Moreover, Sch B reverses brain damage and improves the neurological function of ethanol-treated mice. Therefore, Sch B may serve as a potential treatment option for liver diseases, as well as subsequential brain injuries. Furthermore, Sch B may be useful in preventive drug therapy against alcohol-related diseases.

[1]  Xiankun Tu,et al.  Schisandrin B Inhibits NLRP3 Inflammasome Pathway and Attenuates Early Brain Injury in Rats of Subarachnoid Hemorrhage , 2022, Chinese Journal of Integrative Medicine.

[2]  H. Y. P. Lam,et al.  Resolution of systemic complications in Schistosoma mansoni-infected mice by concomitant treatment with praziquantel and Schisandrin B. , 2021, International journal for parasitology.

[3]  Tinghong Ye,et al.  Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy , 2021, Frontiers in Cell and Developmental Biology.

[4]  Hui Wang,et al.  Inflammasomes and Fibrosis , 2021, Frontiers in Immunology.

[5]  H. Y. P. Lam,et al.  Ameliorative effects of Schisandrin B on Schistosoma mansoni-induced hepatic fibrosis in vivo , 2021, PLoS neglected tropical diseases.

[6]  J. M. Stephen,et al.  Effect of alcohol on the central nervous system to develop neurological disorder: pathophysiological and lifestyle modulation can be potential therapeutic options for alcohol-induced neurotoxication , 2021, AIMS neuroscience.

[7]  Yuyu Zhang,et al.  Schisandrin B Protects against Acute Ethanol-Induced Cardiac Injury by Downregulating Autophagy via the NOX4/ROS Pathway , 2021, Pharmacology.

[8]  H. Y. P. Lam,et al.  An In-vivo Study into the Effects of Schisandrin B in the Liver, Spleen, Kidney, and Brain of Acute Thioacetamide-intoxicated Mice , 2021, Iranian journal of pharmaceutical research : IJPR.

[9]  Jingxiao Gu,et al.  Schisandrin B improves cerebral ischemia and reduces reperfusion injury in rats through TLR4/NF-κB signaling pathway inhibition , 2020, Neurological research.

[10]  Shinn-Jong Jiang,et al.  Albendazole-Schisandrin B Co-Therapy on Angiostrongylus cantonensis-Induced Meningoencephalitis in Mice , 2020, Biomolecules.

[11]  Alexandros T. Tzallas,et al.  Quantification of Liver Fibrosis—A Comparative Study , 2020 .

[12]  Xu Chao,et al.  Schisandrin B suppresses liver fibrosis in rats by targeting miR-101-5p through the TGF-β signaling pathway , 2020, Artificial cells, nanomedicine, and biotechnology.

[13]  J. McGavock,et al.  Improving Knowledge that Alcohol Can Cause Cancer is Associated with Consumer Support for Alcohol Policies: Findings from a Real-World Alcohol Labelling Study , 2020, International journal of environmental research and public health.

[14]  J. Ting,et al.  The NLRP3 inflammasome: molecular activation and regulation to therapeutics , 2019, Nature Reviews Immunology.

[15]  M. Korostyński,et al.  Ethanol consumption following mild traumatic brain injury is related to blood‐brain barrier permeability , 2018, Addiction biology.

[16]  S. Friedman,et al.  Hepatic stellate cells as key target in liver fibrosis. , 2017, Advanced drug delivery reviews.

[17]  E. Miao,et al.  Gasdermins: Effectors of Pyroptosis. , 2017, Trends in cell biology.

[18]  Guoqing Zhang,et al.  Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways , 2017, Drug design, development and therapy.

[19]  X. Yang,et al.  Schisandrin B attenuates the inflammatory response, oxidative stress and apoptosis induced by traumatic spinal cord injury via inhibition of p53 signaling in adult rats , 2017, Molecular medicine reports.

[20]  P. Ferenci Hepatic encephalopathy , 2017, Gastroenterology report.

[21]  F. Wang,et al.  Protective Effects of Lemon Juice on Alcohol-Induced Liver Injury in Mice , 2017, BioMed research international.

[22]  Na Liu,et al.  Anti-Inflammatory Effects of Schisandrin B on LPS-Stimulated BV2 Microglia via Activating PPAR-γ , 2017, Inflammation.

[23]  J. Connor Alcohol consumption as a cause of cancer , 2017, Addiction.

[24]  K. Kharbanda,et al.  Alcoholic Liver Disease: Pathogenesis and Current Management , 2017, Alcohol research : current reviews.

[25]  K. Ko,et al.  Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease , 2016, Oxidative medicine and cellular longevity.

[26]  Fang Wang,et al.  The Effects of Syzygium samarangense, Passiflora edulis and Solanum muricatum on Alcohol-Induced Liver Injury , 2016, International journal of molecular sciences.

[27]  Xiaohui Yang,et al.  Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells , 2016, Oncology reports.

[28]  Shailender Singh,et al.  Alcoholic pancreatitis: New insights into the pathogenesis and treatment. , 2016, World journal of gastrointestinal pathophysiology.

[29]  Lei Zhang,et al.  TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis , 2016, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  Chuan-Qi Zhong,et al.  Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion , 2015, Cell Research.

[31]  J. Hartikainen,et al.  Alcohol Abuse Increases Rebleeding Risk and Mortality in Patients with Non-variceal Upper Gastrointestinal Bleeding , 2015, Digestive Diseases and Sciences.

[32]  M. Swain,et al.  Liver–brain interactions in inflammatory liver diseases: Implications for fatigue and mood disorders , 2014, Brain, Behavior, and Immunity.

[33]  B. Gao,et al.  Mouse model of chronic and binge ethanol feeding (the NIAAA model) , 2013, Nature Protocols.

[34]  D. Lee,et al.  Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague-Dawley rats. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[35]  M. Huang,et al.  Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo. , 2012, The American journal of Chinese medicine.

[36]  D. Kim,et al.  Alcoholism and Diabetes Mellitus , 2012, Diabetes & metabolism journal.

[37]  E. Negri,et al.  Alcohol Consumption and Cancer Risk , 2011, Nutrition and cancer.

[38]  Na Chen,et al.  Schisandrin B co-treatment ameliorates the impairment on mitochondrial antioxidant status in various tissues of long-term ethanol treated rats. , 2010, Fitoterapia.

[39]  D. Mirza,et al.  Liver transplantation for alcoholic liver disease. , 2010, World journal of gastroenterology.

[40]  S. Zakhari Overview: How Is Alcohol Metabolized by the Body? , 2006, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[41]  D. Ferriero,et al.  Manipulation of Antioxidant Pathways in Neonatal Murine Brain , 2004, Pediatric Research.

[42]  C. Lieber,et al.  Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. , 2004, Alcohol.

[43]  K. Weissenborn,et al.  Neurology and the liver , 1997, Journal of neurology, neurosurgery, and psychiatry.

[44]  T. Macmath Alcohol and gastrointestinal bleeding. , 1990, Emergency medicine clinics of North America.

[45]  S. Ohman,et al.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. , 1977, Scandinavian journal of clinical and laboratory investigation.

[46]  G. Tibbling,et al.  Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. , 1977, Scandinavian journal of clinical and laboratory investigation.